GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Machinery, Furniture, Equipment

AngioLab (XKRX:251280) Machinery, Furniture, Equipment : ₩561.6 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Machinery, Furniture, Equipment?

AngioLab's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was ₩561.6 Mil.

AngioLab's quarterly Machinery, Furniture, Equipment increased from Dec. 2021 (₩503.9 Mil) to Dec. 2022 (₩535.3 Mil) and increased from Dec. 2022 (₩535.3 Mil) to Dec. 2023 (₩561.6 Mil).

AngioLab's annual Machinery, Furniture, Equipment increased from Dec. 2021 (₩503.9 Mil) to Dec. 2022 (₩535.3 Mil) and increased from Dec. 2022 (₩535.3 Mil) to Dec. 2023 (₩561.6 Mil).


AngioLab Machinery, Furniture, Equipment Historical Data

The historical data trend for AngioLab's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Machinery, Furniture, Equipment Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Machinery, Furniture, Equipment
Get a 7-Day Free Trial 463.01 500.23 503.90 535.31 561.64

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Machinery, Furniture, Equipment Get a 7-Day Free Trial 463.01 500.23 503.90 535.31 561.64

AngioLab Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


AngioLab (XKRX:251280) Business Description

Industry
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines